Current News and Events

Concentrics chairing CHPA Task Force to develop OTC Naming Guidance

Posted January 14th, 2015. Filed under Concentrics News, Industry Headlines

Julie Aker, President & CEO, is chairing the CHPA Task Force to develop an OTC Naming Guidance pursuant to comments on the Draft Proprietary Name Guidance.  To date, the Task Force has outlined key principles and explored various approaches to considering names for OTC drugs.  This work is expected to be completed by June 2015.

 

Comments submitted for Draft Proprietary Name Guidance

Posted November 10th, 2014. Filed under Concentrics News, Industry Headlines

Concentrics submitted written comments to the Docket for the Draft Proprietary Name Guidance.  We also submitted the results of a study that was  funded in part by CHPA, regarding “Consumer Navigation and Selection Behaviors for OTC Products.”  This pilot study showed that consumers use the brand name of the product to help them locate and select the products they need.

Concentrics Conducts Industry Research on How Consumer Navigate and Select OTC Products

Posted October 1st, 2014. Filed under Concentrics News, Industry Headlines

In support of changes to the draft FDA guidance on “Best Practices in Proprietary Names,” Concentrics designed and conducted a pilot study involving 200 consumers in order to learn how they navigate and select OTC products in a retail setting.  The data supports the importance of the brand name and trade dress to aid consumers in finding and selecting the OTC products they need.  The Consumer Healthcare Products Association (CHPA) contributed to the funding on this study.

You can request a copy of this paper by completing the contact form at the bottom of this page.

Concentrics Posts Comments on FDA Draft Guidance

Posted September 16th, 2014. Filed under Concentrics News

Concentrics Research has submitted feedback on the FDA draft guidance, “Best Practices in Developing Proprietary Names for Drugs,” released on May 29, 2014.  Concentrics Research has also participated in the task force that worked with the Consumer Healthcare Products Association (CHPA) to provide proposed changes to this guidance.  Concentrics supports CHPA’s position.

 

To request a copy of our response, complete the contact form at the bottom of this page.

Concentrics Attends CHPA RSQ 2014

Posted May 14th, 2014. Filed under Concentrics News

Concentrics Research attended the CHPA 2014 Regulatory, Scientific & Quality Conference in Washington, DC from May 12th thru May 14th. Attendees included Julie Aker, President & CEO; Sara Travis, Director of Operations; Doug Gorr, Director of IT and Solutions; Paul Wissler, Director of Finance and Administration; and Melanie Sells, Manager of Compliance.

2/12/2014: Julie Aker, President & CEO, presented best practices and keys to success in a CHPA sponsored Webinar

Posted February 13th, 2014. Filed under Concentrics News, Industry Headlines

2/12/2014:
Julie Aker, President & CEO, presented best practices and keys to success in a CHPA sponsored Webinar;  Rx-to-OTC Switch Part II: How to Successfully Make the Switch.  Over 30 locations participated in the online webinar with an estimated 10 participants per location (~ 300 participants).  Participants asked great questions about how to develop a well-executed switch strategy.  Concentrics’ presentation materials can be requested by contacting doug.gorr@concentricsresearch.com.

October 21, 2013: Concentrics Research President & CEO will be presenting to FDA

Posted October 10th, 2013. Filed under Concentrics News

October 21, 2013:  Julie Aker, President & CEO will be presenting to FDA about a novel new 1-page patient medication information (PMI) document to be used in place of current consumer medication information.  Joining her will be experts from Novartis and Catalina Marketing.

October 23, 2013: Concentrics to attend CHPA’s Regulatory & Scientific Affairs Committee

Posted October 10th, 2013. Filed under Concentrics News

Q1 2014: Julie Aker to present the differences between Canada and U.S. Rx-to-OTC Switch Guidelines

Posted October 10th, 2013. Filed under Archives

Q1 2014:  Julie Aker, President & CEO, has been invited by Consumer Health Products Canada to present a webinar on the similarities and differences of the Rx-to-OTC Switch Guidelines for Canada and the U.S.

Julie Aker to speak at Brookings to discuss REMS

Posted September 19th, 2013. Filed under Concentrics News

Julie Aker, President & CEO, has been invited to speak at the Brookings Institution in Washington, D.C on September 25th and to be part of an expert panel to discuss the REMS (Risk Evaluation and Mitigation Strategies) process.  This process has been arduous for many sponsors.  Brookings is convening a group of FDA and industry experts to evaluate the current process and explore possibilities for improvement.